Skip to main content

Day: January 30, 2024

Aprea Therapeutics to Present at DDR Inhibitors Summit 2024

DOYLESTOWN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Dr. Oren Gilad, President and CEO, will deliver a presentation at the 7th DDR Inhibitors Summit, to take place January 30 to February 1, 2024 in Boston, MA. “We are excited to have the opportunity to present at the DDR Inhibitors Summit,” said Dr. Oren Gilad. “DDR has been identified as an important pathway for treating cancer, and there is considerable ongoing progress in the development of potential new therapeutics. Aprea is positioned at the forefront of this wave of innovation, and we look forward to providing an update to the oncology community at this year’s summit.”Presentation DetailsTitle:     Prioritizing...

Continue reading

Customs Brokerage Market Size Worth USD 49.58 Billion in 2032 | Emergen Research

Growth in international trade, risk management and compliance, and supply chain optimization are some of the major factors driving the Customs Brokerage Market revenue growth Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global customs brokerage market size was USD 23.78 Billion in 2022 and is expected to register a revenue CAGR of 7.7% during the forecast period. Growth in international trade, risk management and compliance, and supply chain optimization are some of the major factors driving the market revenue growth. Customs brokerage refers to assistance provided by licensed individuals or businesses, known as customs brokers, to facilitate the transportation and delivery of goods across international borders via air, sea, or land. These brokers can be individuals or various business entities, such as partnerships, associations,...

Continue reading

Nucleotide Market Size Worth USD 1,083.2 Million in 2032 | Emergen Research

Increasing awareness among consumers regarding improved bioavailability is a major factor driving market revenue growth Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global nucleotide market size was USD 596.4 Million in 2022 and is expected to register a revenue CAGR of 6.1% during the forecast period. Increasing awareness among consumers regarding improved bioavailability is a major factor driving market revenue growth. For instance, powdered nucleotides can be formulated to enhance their bioavailability, which refers to a fraction of an administered dose that reaches systematic circulation and produces a desired pharmacological effect. Techniques such as particle size reduction, formulation with excipients, or encapsulation technologies can improve solubility and absorption of nucleotides, enhancing their bioavailability and...

Continue reading

Access Control as a Service Market Size Worth USD 4.49 Billion in 2032 | Emergen Research

Rising adoption of Internet of Things (IoT)-based security systems and cloud computing platforms and number of smart infrastructure and smart city projects and remote access control management are major factors driving Access Control as a Service (ACaaS) Market revenue growth Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global Access Control as a Service (ACaaS) market size was USD 990 Million in 2022 and is expected to register a rapid revenue CAGR of 16.4% during the forecast period. Rising adoption of Internet of Things (IoT)-based security systems and cloud computing platforms and number of smart infrastructure and smart city projects, cost-effectiveness of access control solutions, and remote access control management are major factors driving market revenue growth. Access Control as a Service refers to the provision of...

Continue reading

Amniocentesis needle market Size Worth USD 229.4 Million in 2032 | Emergen Research

High reliability and accuracy of amniocentesis test and increasing rate of pregnancy and preference for minimally and non- invasive diagnostic procedures are key factors driving Amniocentesis needle market revenue growth Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global amniocentesis needle market size was USD 172.8 Million in 2022 and is expected to register a rapid revenue CAGR of 2.8% during the forecast period. High reliability and accuracy of amniocentesis test and increasing rate of pregnancy and preference for minimally and non- invasive diagnostic procedures are key factors driving market revenue growth. Amniocentesis, also known as Amniotic Fluid Test (AFT), is a type of prenatal test, which is performed for diagnosis of chromosomal abnormalities and infection in fetus. An amniocentesis often yields reliable findings. An...

Continue reading

Wearable Sensors Market Size Worth USD 11.05 Billion in 2032 | Emergen Research

Increasing health and fitness awareness among people, advancements in microelectronics & sensor manufacturing adopted by leading organizations in this industry, miniaturization trend in sensor manufacturing, and mounting benefits of wearable devices in the healthcare sector are some of the major factors driving the wearable sensors market revenue growth Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global wearable sensors market size was USD 3.41 Billion in 2022 and is expected to register a revenue CAGR of 12.5% during the forecast period. Increasing health and fitness awareness among people, advancements in microelectronics & sensor manufacturing adopted by leading organizations in this industry, miniaturization trend in sensor manufacturing, and mounting benefits of wearable devices in the healthcare sector are some...

Continue reading

Flexible Display Market Size Worth USD 351.36 Billion in 2032 | Emergen Research

Rising demand for greater picture quality, rising innovation in consumer electronics by leading market players, growing adoption of energy-efficient and flexible gadgets across various industries, and rising demand for display-based consumer electronics by population across the globe are some of the major factors driving the flexible display market revenue growth Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global flexible display market size was USD 19.78 Billion in 2022 and is expected to register a revenue CAGR of 33.4% during the forecast period. Rising demand for greater picture quality, rising innovation in consumer electronics by leading market players, growing adoption of energy-efficient and flexible gadgets across various industries, and rising demand for display-based consumer electronics by population across the...

Continue reading

Malibu Boats, Inc. Announces Second Quarter Fiscal 2024 Results

LOUDON, Tenn., Jan. 30, 2024 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the second quarter ended December 31, 2023. Second Quarter Fiscal 2024 Highlights Compared to Second Quarter Fiscal 2023:Net sales decreased 37.7% to $211.1 million Unit volume decreased 43.7% to 1,373 units Gross profit decreased 50.5% to $37.5 million Net income decreased 72.1% to $10.1 million Adjusted EBITDA decreased 60.2% to $22.9 million Net income available to Class A Common Stock per share (diluted) decreased 71.5% to $0.49 per share Adjusted fully distributed net income per share decreased 68.9% to $0.57 per share on a fully distributed weighted-average share count of 21.1 million shares of Class A Common Stock“Our second quarter results, historically our slowest time of the year, were impacted...

Continue reading

Dragonfly Energy Drives the John Lennon Educational Tour Bus Toward Sustainability

The John Lennon Educational Tour Bus Powered by Battle Born Batteries at the 2024 NAMM ShowThe John Lennon Educational Tour Bus Powered by Battle Born Batteries at the 2024 NAMM ShowThe John Lennon Educational Tour Bus is now powered by Battle Born Batteries’ nontoxic lithium batteries, moving the nonprofit mobile recording studio toward improved sustainability. The move to lithium batteries and solar panels allows the nonprofit to enhance their student experiences, increase the organization’s reach, and save money on expensive generator fuel as they share music education across the country. Dragonfly Energy uses sixteen 270Ah 12V Battle Born LiFePO4 deep cycle batteries plus twelve 200W solar panels to power the mobile recording studio off the grid for up to eight hours of runtime with no loud generators. This runtime greatly...

Continue reading

Sparton Announces Final approval of Private Placement Offering for its Critical Metals Exploration Programs

Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the “Company”) is pleased to announce it has received final approval from the TMX Venture Exchange (the “Exchange”) of the non-brokered private placement (the “Offering”) announced on December 8th, 2023. This financing was fully closed effective December 31st, 2023, with conditional approval from the Exchange. Sparton has issued a total of 11,500,000 Flow-Through Share (“FTS”) Units of the Company (each, a FTS Unit”) at a price of C$0.05 per FTS Unit. Each FTS Unit consists of one common share of the Company and a ½ (one half) non-flow through Share Purchase Warrant (“SPW”) for a total of 5,500,000 Full SPWs. These include the Finder Warrants...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.